Decipher Prostate

JSON twin: https://www.healthaidb.com/software/decipher-prostate.json

Company Name

Veracyte

Product URL

https://www.veracyte.com/decipher-prostate/

Company URL

https://www.veracyte.com

Categories

• diagnostic Support
• clinical Care
• oncology Care
• genomics
• Diagnostic
• Clinical
• Oncology
• Genomic Testing

Summary

Decipher Prostate is a 22-gene genomic test developed by Veracyte to assess the risk of prostate cancer metastasis, aiding in personalized treatment decisions for patients with localized or metastatic prostate cancer.

Description

Decipher Prostate is a genomic classifier that evaluates the aggressiveness of prostate cancer by analyzing RNA whole-transcriptome data. It provides a Decipher score indicating the likelihood of metastasis within five years, assisting physicians in tailoring treatment plans. The test is performed on tissue samples obtained during biopsy or surgical removal of the prostate. It has been validated in over 75 peer-reviewed studies involving nearly 110,000 patients and is the only gene expression test included in the NCCN Clinical Practice Guidelines for Prostate Cancer. In April 2025, Veracyte expanded the test's availability to patients with metastatic prostate cancer, making it the only gene expression test covered by Medicare for this patient group. The test is available in the U.S. through Veracyte's CLIA-validated laboratory-developed test (LDT) service and is not FDA-cleared or approved. Veracyte is working to make the test accessible to patients worldwide.

Api Available

unknown

Certifications

• CLIA-validated laboratory developed test (LDT)

Company Founding

2008

Company Offices

• United States

Compliance

• FDA enforcement discretion policy
• CLIA standards

Customers

• Veracyte
• FoundationIP
• PATTSY WAVE
• Inteum
• AppColl
• AQX
• PatentRenewal.com
• Alt Legal
• Legistify
• IPfolio
• Decipher Agency Ltd.

Data Residency

U.S.-based laboratories

Data Standards

• NCCN Clinical Practice Guidelines
• NCI SEER database
• FDA regulations
• CLIA standards

Deployment Model

• SaaS

Features

• 22-gene genomic classifier
• RNA whole-transcriptome analysis
• Machine learning-based risk assessment
• Prognostic tool for localized prostate cancer
• Guides treatment planning
• Assesses risk of metastasis within five years
• Supports personalized treatment decisions
• Utilizes tissue samples from biopsy or prostatectomy
• Validated in over 75 peer-reviewed studies
• Integrated into NCCN Clinical Practice Guidelines
• Level 1B evidence rating
• Presented at ASTRO 2023
• Linked to NCI SEER database
• Predicts chemotherapy benefit in metastatic prostate cancer
• FDA enforcement discretion policy compliant
• CLIA-validated laboratory developed test (LDT)
• Not FDA-cleared or approved
• Available in the U.S.
• Not for use to support treatment decisions
• Decipher GRID database for research use only

Id

SW2590

Integration Partners

• Salesforce
• Oracle
• SAP
• HubSpot

Integrations

• NCCN Clinical Practice Guidelines
• NCI SEER database
• ASTRO 2023 conference
• FDA enforcement discretion policy
• CLIA laboratory developed test (LDT)

Languages Supported

• English

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise
• consumer

Optional Modules

Os Platforms

• Web

Pricing Details

contact vendor

Pricing Model

subscription

Privacy Features

• Data anonymization
• Compliance with HIPAA regulations
• Patient consent management
• Data minimization

Product Code

SW2590

Product Name

Decipher Prostate

Ratings

• 4.3 out of 5 on G2
• 4.4 out of 5 on G2
• 4.0 out of 5 on G2
• 4.8 out of 5 on G2

Regions Available

• United States

Related Urls

Release Year

2010

Security Features

• Data encryption
• Access controls
• Audit trails
• Data anonymization
• Compliance with HIPAA regulations

Specialties

• Oncology
• Urology

Support Channels

• email
• phone
• chat
• ticketing
• community
• 24x7

System Requirements

Target Users

• clinicians
• patients

Training Options

• documentation
• webinars
• live_online
• onsite
• certification

Type

product

User Reviews

• Decipher is a powerful point-and-click, survey-building software. We like that you can quickly build professional-looking surveys while still having the ability to use custom code. In addition, if things get difficult, they offer a full-service option.
• The intuitive GUI system makes building surveys easy without needing coding knowledge, but coding can be used to create deeper questions. It's been a quick platform to learn which is a testament to Decipher.
• I like multiple reports formats which is available in decipher.
• Not suitable where we have having some balancing required based on quotas. Markers concept.
• Ease of Use- interface is easy to learn. I like that it has the capability to web validate some countries, but it is unfortunate that the ability to web validate all of the 'most filed in' countries are not available.

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "Decipher Prostate",
  "company_name": "Veracyte",
  "product_url": "https://www.veracyte.com/decipher-prostate/",
  "company_url": "https://www.veracyte.com",
  "related_urls": [],
  "product_code": "SW2590",
  "summary": "Decipher Prostate is a 22-gene genomic test developed by Veracyte to assess the risk of prostate cancer metastasis, aiding in personalized treatment decisions for patients with localized or metastatic prostate cancer.",
  "description": "Decipher Prostate is a genomic classifier that evaluates the aggressiveness of prostate cancer by analyzing RNA whole-transcriptome data. It provides a Decipher score indicating the likelihood of metastasis within five years, assisting physicians in tailoring treatment plans. The test is performed on tissue samples obtained during biopsy or surgical removal of the prostate. It has been validated in over 75 peer-reviewed studies involving nearly 110,000 patients and is the only gene expression test included in the NCCN Clinical Practice Guidelines for Prostate Cancer. In April 2025, Veracyte expanded the test's availability to patients with metastatic prostate cancer, making it the only gene expression test covered by Medicare for this patient group. The test is available in the U.S. through Veracyte's CLIA-validated laboratory-developed test (LDT) service and is not FDA-cleared or approved. Veracyte is working to make the test accessible to patients worldwide.",
  "categories": [
    "diagnostic Support",
    "clinical Care",
    "oncology Care",
    "genomics",
    "Diagnostic",
    "Clinical",
    "Oncology",
    "Genomic Testing"
  ],
  "market_segment": [
    "enterprise",
    "consumer"
  ],
  "target_users": [
    "clinicians",
    "patients"
  ],
  "specialties": [
    "Oncology",
    "Urology"
  ],
  "regions_available": [
    "United States"
  ],
  "languages_supported": [
    "English"
  ],
  "pricing_model": "subscription",
  "pricing_details": "contact vendor",
  "license": "commercial",
  "company_offices": [
    "United States"
  ],
  "company_founding": "2008",
  "deployment_model": [
    "SaaS"
  ],
  "os_platforms": [
    "Web"
  ],
  "features": [
    "22-gene genomic classifier",
    "RNA whole-transcriptome analysis",
    "Machine learning-based risk assessment",
    "Prognostic tool for localized prostate cancer",
    "Guides treatment planning",
    "Assesses risk of metastasis within five years",
    "Supports personalized treatment decisions",
    "Utilizes tissue samples from biopsy or prostatectomy",
    "Validated in over 75 peer-reviewed studies",
    "Integrated into NCCN Clinical Practice Guidelines",
    "Level 1B evidence rating",
    "Presented at ASTRO 2023",
    "Linked to NCI SEER database",
    "Predicts chemotherapy benefit in metastatic prostate cancer",
    "FDA enforcement discretion policy compliant",
    "CLIA-validated laboratory developed test (LDT)",
    "Not FDA-cleared or approved",
    "Available in the U.S.",
    "Not for use to support treatment decisions",
    "Decipher GRID database for research use only"
  ],
  "optional_modules": [],
  "integrations": [
    "NCCN Clinical Practice Guidelines",
    "NCI SEER database",
    "ASTRO 2023 conference",
    "FDA enforcement discretion policy",
    "CLIA laboratory developed test (LDT)"
  ],
  "data_standards": [
    "NCCN Clinical Practice Guidelines",
    "NCI SEER database",
    "FDA regulations",
    "CLIA standards"
  ],
  "api_available": "unknown",
  "system_requirements": "",
  "compliance": [
    "FDA enforcement discretion policy",
    "CLIA standards"
  ],
  "certifications": [
    "CLIA-validated laboratory developed test (LDT)"
  ],
  "security_features": [
    "Data encryption",
    "Access controls",
    "Audit trails",
    "Data anonymization",
    "Compliance with HIPAA regulations"
  ],
  "privacy_features": [
    "Data anonymization",
    "Compliance with HIPAA regulations",
    "Patient consent management",
    "Data minimization"
  ],
  "data_residency": "U.S.-based laboratories",
  "customers": [
    "Veracyte",
    "FoundationIP",
    "PATTSY WAVE",
    "Inteum",
    "AppColl",
    "AQX",
    "PatentRenewal.com",
    "Alt Legal",
    "Legistify",
    "IPfolio",
    "Decipher Agency Ltd."
  ],
  "user_reviews": [
    "Decipher is a powerful point-and-click, survey-building software. We like that you can quickly build professional-looking surveys while still having the ability to use custom code. In addition, if things get difficult, they offer a full-service option.",
    "The intuitive GUI system makes building surveys easy without needing coding knowledge, but coding can be used to create deeper questions. It's been a quick platform to learn which is a testament to Decipher.",
    "I like multiple reports formats which is available in decipher.",
    "Not suitable where we have having some balancing required based on quotas. Markers concept.",
    "Ease of Use- interface is easy to learn. I like that it has the capability to web validate some countries, but it is unfortunate that the ability to web validate all of the 'most filed in' countries are not available."
  ],
  "ratings": [
    "4.3 out of 5 on G2",
    "4.4 out of 5 on G2",
    "4.0 out of 5 on G2",
    "4.8 out of 5 on G2"
  ],
  "support_channels": [
    "email",
    "phone",
    "chat",
    "ticketing",
    "community",
    "24x7"
  ],
  "training_options": [
    "documentation",
    "webinars",
    "live_online",
    "onsite",
    "certification"
  ],
  "release_year": "2010",
  "integration_partners": [
    "Salesforce",
    "Oracle",
    "SAP",
    "HubSpot"
  ],
  "id": "SW2590",
  "slug": "decipher-prostate",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/decipher-prostate.json"
  }
}